OnKure Therapeutics (OKUR) Other Non-Current Assets (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Other Non-Current Assets for 7 consecutive years, with $401000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 245.69% year-over-year to $401000.0; the trailing twelve-month figure through Jun 2026 stood at $401000.0 (up 245.69% YoY), and the FY2025 full-year result was $273000.0, up 150.46% from the prior year.
• Other Non-Current Assets eased to $401000.0 in Q2 2026 per OKUR's latest filing, from $405000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $405000.0 in Q1 2026 and bottomed at $58000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $138833.3 across 5 years, with a median of $94000.0 in 2022.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets slumped 95.36% in 2022, then soared 271.56% in 2026.
• Over 5 years, Other Non-Current Assets stood at $84000.0 in 2022, then slumped by 30.95% to $58000.0 in 2023, then jumped by 87.93% to $109000.0 in 2024, then surged by 150.46% to $273000.0 in 2025, then surged by 46.89% to $401000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $401000.0, $405000.0, and $273000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.